Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mandell

Showing results (11-20 of 146) with videos related to

Pageof 15
Sort By:
The International Journal of the Addictions|December 1, 1993
Depression as an antecedent of frequency of intravenous drug use in an urban, nontreatment sampleC A Latkin, W Mandell
Alcoholism, Clinical and Experimental Research|January 1, 1983
Male sexual dysfunction as related to alcohol consumption: a pilot studyW Mandell, C M Miller
Brain Research. Molecular Brain Research|May 17, 2005
Differential localization of MAPK-activated protein kinases RSK1 and MSK1 in mouse brainDaniel Heffron, James W Mandell
American Journal of Public Health|May 1, 1990
Risk factors for depressive symptomatology in a drug using populationJ C Buckner, W Mandell
Antimicrobial Agents and Chemotherapy|May 1, 1986
Antimicrobial activity and beta-lactamase stability of foramidocillinW Mandell, H C Neu
Antimicrobial Agents and Chemotherapy|May 1, 1986
In vitro activity of CI-934, a new quinolone, compared with that of other quinolones and other antimicrobial agentsW Mandell, H C Neu
Journal of Clinical Microbiology|November 1, 1985
Disk susceptibility of ofloxacin, a new carboxyquinoloneW Mandell, H C Neu
Journal of Neurotrauma|July 18, 2003
Transient neuronal but persistent astroglial activation of ERK/MAP kinase after focal brain injury in miceW Shawn Carbonell, James W Mandell
Brain Research|August 21, 2007
A pharmacological activator of AMP-activated protein kinase (AMPK) induces astrocyte stellationCarlita B Favero, James W Mandell
Molecular and Cellular Neurosciences|March 31, 2005
Opposing roles of ERK and p38 MAP kinases in FGF2-induced astroglial process extensionDaniel S Heffron, James W Mandell
Pageof 15

Showing results (11-20 of 146) with videos related to

Sort By:
Pageof 15
The International Journal of the Addictions|December 1, 1993
Depression as an antecedent of frequency of intravenous drug use in an urban, nontreatment sampleC A Latkin, W Mandell
Alcoholism, Clinical and Experimental Research|January 1, 1983
Male sexual dysfunction as related to alcohol consumption: a pilot studyW Mandell, C M Miller
Brain Research. Molecular Brain Research|May 17, 2005
Differential localization of MAPK-activated protein kinases RSK1 and MSK1 in mouse brainDaniel Heffron, James W Mandell
American Journal of Public Health|May 1, 1990
Risk factors for depressive symptomatology in a drug using populationJ C Buckner, W Mandell
Antimicrobial Agents and Chemotherapy|May 1, 1986
Antimicrobial activity and beta-lactamase stability of foramidocillinW Mandell, H C Neu
Antimicrobial Agents and Chemotherapy|May 1, 1986
In vitro activity of CI-934, a new quinolone, compared with that of other quinolones and other antimicrobial agentsW Mandell, H C Neu
Journal of Clinical Microbiology|November 1, 1985
Disk susceptibility of ofloxacin, a new carboxyquinoloneW Mandell, H C Neu
Journal of Neurotrauma|July 18, 2003
Transient neuronal but persistent astroglial activation of ERK/MAP kinase after focal brain injury in miceW Shawn Carbonell, James W Mandell
Brain Research|August 21, 2007
A pharmacological activator of AMP-activated protein kinase (AMPK) induces astrocyte stellationCarlita B Favero, James W Mandell
Molecular and Cellular Neurosciences|March 31, 2005
Opposing roles of ERK and p38 MAP kinases in FGF2-induced astroglial process extensionDaniel S Heffron, James W Mandell
Pageof 15